Bingxiu Xiao

9.1k citations
79 papers · 7.4k indexed · 1 hit paper · h-index 45

Bingxiu Xiao

77 papers receiving 7.3k citations

Hit Papers

Using circular RNA as a novel type of biomarker in the sc...6522015202620182022200400600

Peers

Bingxiu Xiao
Comparison fields: 5 of 117
  • Cancer Research 5.8k
  • Molecular Biology 6.3k
  • Toxicology 95
  • Plant Science 624
  • Pathology and Forensic Medicine 275
Replace Hui Ling with:
Hui Ling China
Ting Li China
Youwei Zhang China
Abdelilah Aboussekhra Saudi Arabia
Qing Tang China
Yuanyuan Lu China
Fei Chen China
Jichun Zhou China
Zhaohui Gong China
Dianzheng Zhang United States
Bingxiu Xiao relative to Hui Ling China Hui Ling's profile →
Citations per field
00.5×2.9×
Hui Ling · 1×
Citations per year

Countries citing papers authored by Bingxiu Xiao

Since Specialization
Citations

This map shows the geographic impact of Bingxiu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxiu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxiu Xiao more than expected).

Fields of papers citing papers by Bingxiu Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxiu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxiu Xiao. The network helps show where Bingxiu Xiao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bingxiu Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bingxiu Xiao Line = papers co-authored together Bingxiu Xiao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202416
2 201986
3 2015128
4 2014150
5 2014342
6 2013196
7 201384
8 2011269
9 2011234
10 201099
11 2008402
12
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
20071
13 200778
14 200726
15 200744
16 200734
17 200521
18 200434
19 200443
20 200443

About Bingxiu Xiao

Bingxiu Xiao is a scholar working on Cancer Research, Molecular Biology and Toxicology, having authored 79 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (44 papers), MicroRNA in disease regulation (39 papers), Circular RNAs in diseases (31 papers), RNA modifications and cancer (11 papers), RNA Research and Splicing (8 papers), Phytochemistry and biological activity of medicinal plants (5 papers), Mycobacterium research and diagnosis (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (5.8k citations), Molecular Biology (6.3k citations) and Toxicology (95 citations). Bingxiu Xiao has collaborated with scholars based in China, South Korea and Canada. Frequent co-authors include Junming Guo, Yongfu Shao, Tianwen Li, Zhen Jiang, Tian Xia, Xinjun Zhang, Guoliang Ye, Ying Miao, Weiliang Sun and Xiaoyan Mo. Their work appears in journals such as Nature Communications, Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026